TRIB3 and breast carcinoma: TRIB3 is positively associated with breast cancer stemness and progression by inhibiting FOXO1 degradation and increasing SOX2 transcription [45] and the cellular stress-activated TRB3/USP9x-dependent Notch pathway in breast cancer [46].